DCU Life Sciences Institute
Naomi Walsh webinar: "Novel 3-D In Vitro Models for Studying Pancreatic Cancer Drug Response and Resistance"
Dr. Naomi Walsh's (MPH, PhD) current research is focused on developing organoid 3D cancer systems to model the genomic and transcriptomic landscape of rare and difficult to cure cancers such as pancreatic cancer to identify novel therapeutic combinations, and strategies to overcome drug resistance. She recently presented a webinar for the American Type Culture Collection (ATCC) entitled “Novel 3-D In Vitro Models for Studying Pancreatic Cancer Drug Response and Resistance”. The link to the webinar is available here: